People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ClearNote Health, Inc. | — | Biotechnology | Series C | $91.1M | $137.7M | 2019 |
| Impact Genomics, Inc. | — | Biotech | Series A | $10.2M | $369.3M | 2015 |
Samuel Levy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samuel Levy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Mullarkey | 1 | 2 |
| Stephen Quake | 1 | 2 |
| Samuel Mattias Levy | 1 | 1 |
| Johan Mattias Westman | 1 | 1 |
| Johan Mattias Westerman | 1 | 1 |
| John Spinosa | 1 | 1 |
| Kenneth Nesmith | 1 | 1 |
| Tina Mattias Nova | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.